C1566558||Natural product derivative
C1254351||BIO
C2004454||recovery
C0027051||myocardial infarction
C0443264||modulation
C0018787||cardiac
C0018787||cardiac
C0225828||cardiomyocytes
C0016030||fibroblasts
C0024432||macrophages
C1327622||regulate
C3658220||remodeling
C0027051||myocardial infarction
C0027051||myocardial infarction
C0087111||therapeutic approach
C0027051||myocardial infarction
C1566558||natural compound derivative
C1254351||BIO
C1254351||((2'Z,3'E)-6-Bromoindirubin-3'-oxime)
C0443264||modulated
C0018787||cardiac
C1527144||therapeutic effect
C0027051||myocardial infarction
C0282547||co-culture studies
C1254351||BIO
C0596290||proliferation
C0225828||cardiomyocytes
C0596290||proliferation
C0018787||cardiac
C0016030||fibroblasts
C1254351||BIO
C0243095||anti-fibrotic effects
C0018787||cardiac
C0016030||fibroblasts
C0024432||macrophages
C1254351||BIO
C1254351||BIO
C0443264||modulated
C0010357||crosstalk
C0018787||cardiac
C0016030||fibroblasts
C0024432||macrophages
C0007613||polarization
C0243095||anti-inflammatory
C4086555||M2
C3161035||optically transparent zebrafish-based heart failure model
C1254351||BIO
C0225828||cardiomyocyte
C0596290||proliferation
C1254351||BIO
C0244988||glycogen synthase kinase-3Î²
C0243077||inhibitor
C0243077||classical inhibitor
C0065088||lithium chloride
C1527144||therapeutic effects
C1254351||BIO
C1254351||BIO
C0443264||modulation
C0598086||p27
C1171362||protein expression
C0243095||anti-inflammatory
C0085295||interleukin-10
C0086272||rat MI model
C1254351||BIO
C0016059||fibrosis
C0184511||improved
C0018787||cardiac
C0936012||analysis
C0443264||modulation
C0018787||cardiac
C1254351||BIO
C0150312||presence
C0243095||anti-inflammatory
C4086555||M2 macrophages
C1254351||BIO
C0018787||cardiac
C2004454||recovery